Stock Updates

Teva Pharmaceutical Industries Limited (NYSE: TEVA) – Is this large market cap stock undervalued?

Teva Pharmaceutical Industries Limited (NYSE: TEVA), is firmly in the large market cap category with market cap of 52590.09. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Teva Pharmaceutical Industries Limited is 50.94 (with a change from open of -1.16%), this in conjunction with a target price of 68.77. Volume today has so far reached 1305680, with an average volume of about 5895.71. The GAP for this stock, is -0.39%.

The P/E ratio is 34.54, bringing the forward P/E to a value of 8.72. The current EPS for Teva Pharmaceutical Industries Limited, is 1.5, with a EPS growth for this year coming to a value of -48.90%. Performance has been interesting with performance year to date coming to -19.66%.

Looking further into the growth statistics for Teva Pharmaceutical Industries Limited, EPS is looking like it will grow 12.92% in the next year. Looking even further it is projected to be 5.70%. Quarter over quarter is -67.40% for EPS growth and for sales growth quarter over quarter it is 1.40%. Looking at past EPS growth statistics we see that for the past five years it has been -13.10%. Sales growth for the past five years has in fact been 4.00%.

Looking at the ownership, we see that the insider ownership is at 2.70% and institutional ownership is 59.20%. Shares outstanding is 1016.43, while shares float is at a value of 1014.36. Float short for Teva Pharmaceutical Industries Limited is 0.97% and the short ratio is 1.67.

In terms of debt, long term debt/equity is 0.27, while the total debt/equity comes to 0.36. The ability to meet these debts, means that the current ratio is 1.3, and the quick ratio is 1. The most recent gross margin is 57.70% and their operating margin is 17.70%. The profit margin is 6.90%.

Teva Pharmaceutical Industries Limited has seen returns on assets of 2.50%, and on investment, 5.70%. Return on equity is 4.90%. Price/Earnings to growth ratio is 6.06. Price/Sales ratio is at a value of 2.69, with Price/book ratio coming to 1.57 and Price/cash is 7.53, and finally Price/Free cash Flow is 10.42.

The simple moving averages are -3.28% and -7.98% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -21.98% and the 52 week low is 6.79%.

Teva Pharmaceutical Industries Limited has a dividend yield of 2.63%, with a current price of 50.94. The ability to pay this means the payout ratio is 67.50%. This is in an industry, Drug Manufacturers – Other, with equally high dividends from other companies in this sector, which it is Healthcare. Teva Pharmaceutical Industries Limited is based in Israel.

Performance in the Drug Manufacturers – Other industry means that Teva Pharmaceutical Industries Limited has seen performance for the past week of 3.05%, with performance for the month coming to -1.90%. Looking at the data for the quarter it is at a value of 0.12%, and for the half year the performance is -17.62%. Volatility for this week is 1.94% and for the month this is 2.02%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment